FI118768B - Förfarande för framställning av antifungala cykliska peptider - Google Patents

Förfarande för framställning av antifungala cykliska peptider Download PDF

Info

Publication number
FI118768B
FI118768B FI931202A FI931202A FI118768B FI 118768 B FI118768 B FI 118768B FI 931202 A FI931202 A FI 931202A FI 931202 A FI931202 A FI 931202A FI 118768 B FI118768 B FI 118768B
Authority
FI
Finland
Prior art keywords
formula
phenyl
benzoyl
compounds
groups
Prior art date
Application number
FI931202A
Other languages
English (en)
Finnish (fi)
Other versions
FI931202A (fi
FI931202A0 (fi
Inventor
Manuel Debono
Jeffrey Scott Nissen
Frederick Joseph Burkhardt
Jr William Wilson Turner
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of FI931202A0 publication Critical patent/FI931202A0/fi
Publication of FI931202A publication Critical patent/FI931202A/fi
Application granted granted Critical
Publication of FI118768B publication Critical patent/FI118768B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • C07K7/66—Gramicidins S, C; Tyrocidins A, B, C; Related peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Claims (5)

1. Förfarande för framställning av en terapeutiskt användbar förening med formeln 5 HO OH HQ 9 /—( g _t HQ H HN CH3 / V--A.H m Vj, o=/ 0H «Γν*τ·Cl W O f^J0H HO där R är -0(CH2)3CH3, -0(CH2)4CH3i -0(CH2)5CH3, -0(CH2)20 (CH2)3CH3 eller -0 (CH2) 20C (CH) 3, kännetecknat av att aminokärnan av echinocandin B acy- »#· · *. 10 leras med en aktiv ester av en karboxylsyra med formeln ·»· : : ··« : p *· *i H /*sev yes'· .«sv ·· *_ * · · i · • * • M
• · · • · ♦ • 2. Förfarande enligt patentkrav 1, kännetecknat 15 av att R är -0(CH2)4CH3.
• · * ” 3. Förfarande enligt patentkrav 1 eller 2, kän- :.··! netecknat av att den aktiva estern är 2,4,5-triklor- ·*·.: fenylester.
• · ·:··· 4. Förfarande enligt nägot av patentkraven 1-3, 20 kännetecknat av att aminokärnan av echinocandin B er- • *1# * ; hälls genom att N-deacylera en i naturen förekommande cy- klisk hexapeptid. 118768
5. Förfarande enligt patentkrav 4, kännetecknat av att den i naturen förekommande cykliska hexapeptiden är echinocandin B, tetrahydro-echinocandin B, mulundocandin, L-671 329, S 31794/FI, sporiofungin eller FR901379. • » • · ♦ • · · • · »«» • · • 1 ··· • · • · · • M • « • · ·· · • « « • · • · • M f 1 1 ♦ · · ·· • 1 • ·· ··· • · • · ··· • · · • ♦ · * · » · * • 1 I · · • ·· • ·
FI931202A 1992-03-19 1993-03-18 Förfarande för framställning av antifungala cykliska peptider FI118768B (sv)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US85411792A 1992-03-19 1992-03-19
US85411792 1992-03-19
US99239092A 1992-12-16 1992-12-16
US99239092 1992-12-16

Publications (3)

Publication Number Publication Date
FI931202A0 FI931202A0 (fi) 1993-03-18
FI931202A FI931202A (fi) 1993-09-20
FI118768B true FI118768B (sv) 2008-03-14

Family

ID=27127211

Family Applications (1)

Application Number Title Priority Date Filing Date
FI931202A FI118768B (sv) 1992-03-19 1993-03-18 Förfarande för framställning av antifungala cykliska peptider

Country Status (25)

Country Link
EP (1) EP0561639B1 (sv)
JP (3) JP3519754B2 (sv)
KR (1) KR100256036B1 (sv)
CN (1) CN1036715C (sv)
AT (1) ATE217635T1 (sv)
AU (2) AU3534193A (sv)
BR (1) BR9301232A (sv)
CA (1) CA2091663C (sv)
CZ (1) CZ288974B6 (sv)
DE (2) DE69331922T2 (sv)
DK (1) DK0561639T3 (sv)
ES (1) ES2174843T3 (sv)
FI (1) FI118768B (sv)
HU (2) HU225783B1 (sv)
IL (3) IL105048A (sv)
LU (1) LU91406I2 (sv)
MX (1) MX9301457A (sv)
MY (1) MY136593A (sv)
NL (1) NL300334I2 (sv)
NO (1) NO930948L (sv)
NZ (3) NZ512085A (sv)
PT (1) PT561639E (sv)
RU (1) RU2129562C1 (sv)
TW (1) TW264477B (sv)
YU (1) YU49108B (sv)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5430018A (en) * 1991-10-17 1995-07-04 Merck & Co., Inc. Cyclohexapeptide with basic nitrogen containing alkylamide groups
CZ288974B6 (cs) * 1992-03-19 2001-10-17 Eli Lilly And Company Acylový derivát echinocandinu, způsob jeho přípravy, farmaceutický prostředek s jeho obsahem a jeho pouľití
US6743777B1 (en) 1992-03-19 2004-06-01 Eli Lilly And Company Cyclic peptide antifungal agents and process for preparation thereof
US5378804A (en) * 1993-03-16 1995-01-03 Merck & Co., Inc. Aza cyclohexapeptide compounds
US5948753A (en) * 1993-05-04 1999-09-07 Merck & Co., Inc. Cyclohexapeptidyl propanolamine compounds
CA2161149A1 (en) * 1993-05-04 1994-11-10 James M. Balkovec Cyclohexapeptidyl aminoalkyl ethers
AU7874494A (en) * 1993-09-22 1995-04-10 Merck & Co., Inc. Antifungal and anti-pneumocystis compounds, compositions containing such compounds, and methods of use
US5516757A (en) * 1994-09-16 1996-05-14 Merck & Co., Inc. Semi-synthetic lipopeptides, compositions containing said lipopeptides, and methods of use
US5514651A (en) * 1994-09-16 1996-05-07 Merck & Co., Inc. Aza cyclohexapeptide compounds
ATE223226T1 (de) * 1994-09-16 2002-09-15 Merck & Co Inc Azazyklohexapeptid-verbindungen
US6107458A (en) * 1994-10-07 2000-08-22 Fujisawa Pharmaceutical Co., Ltd. Cyclic hexapeptides having antibiotic activity
US5516756A (en) * 1994-10-31 1996-05-14 Merck & Co., Inc. Aza cyclohexapeptide compounds
CA2211138A1 (en) * 1995-01-26 1996-08-01 Merck & Co., Inc. Novel antifungal cyclohexapeptides
US5646111A (en) * 1995-04-07 1997-07-08 Eli Lilly And Company Cyclic peptide antifungal Agents
US5629290A (en) * 1995-05-26 1997-05-13 Eli Lilly And Company Cyclic peptide antifungal agents
US5652213A (en) * 1995-05-26 1997-07-29 Eli Lilly And Company Cyclic peptide antifungal agents
US5618787A (en) * 1995-05-26 1997-04-08 Eli Lilly And Company Cyclic peptide antifungal agents
US5786325A (en) * 1995-05-26 1998-07-28 Eli Lilly And Company Cyclic peptide antifungal agents and methods of making and using
US5629289A (en) * 1995-07-25 1997-05-13 Eli Lilly And Company Cyclic peptide antifungal agents
JP2001503015A (ja) * 1996-02-01 2001-03-06 イーライ・リリー・アンド・カンパニー 環状ペプチド抗真菌剤
US5693611A (en) * 1996-02-01 1997-12-02 Eli Lilly And Company Cyclic peptide antifungal agents
JPH09227422A (ja) * 1996-02-12 1997-09-02 Rolic Ag シクロペンチル誘導体
US5696084A (en) * 1996-08-16 1997-12-09 Abbott Laboratories Amino-lipopetide antifungal agents
AUPO381496A0 (en) * 1996-11-25 1996-12-19 Fujisawa Pharmaceutical Co., Ltd. New compound
FR2784993B1 (fr) * 1998-10-26 2002-10-31 Hoechst Marion Roussel Inc Nouveaux derives de l'echinocandine, leur procede de preparation et leur application comme fongicides
AU2003200556B2 (en) * 1997-12-10 2005-12-01 Novexel Echinocandin derivative and their preparation method
UA72200C2 (uk) 1997-12-10 2005-02-15 Авентіс Фарма С.А. Похідні ехінокандину, спосіб їх одержання, їх застосування, проміжні сполуки та фармацевтична композиція
US6730776B1 (en) * 1998-03-16 2004-05-04 Fujisawa Pharmaceutical Co., Ltd. WF14573 or its salt, production thereof and use thereof
EP1107981B1 (en) 1998-08-20 2005-01-26 Eli Lilly & Company Synthesis of ring-modified cyclic peptide analogs
PT1137663E (pt) 1998-12-09 2006-12-29 Lilly Co Eli Purificação de compostos ciclopéptidos equinocandina
DE19907904A1 (de) 1999-02-24 2000-08-31 Clariant Gmbh Verfahren zur Herstellung von [1,1':4',1"]-Terphenylverbindungen
CA2362481C (en) * 1999-03-03 2008-11-04 Eli Lilly And Company Echinocandin pharmaceutical formulations containing micelle-forming surfactants
WO2000052037A1 (en) 1999-03-03 2000-09-08 Eli Lilly And Company Echinocandin/carbohydrate complexes
KR20020002476A (ko) 1999-03-03 2002-01-09 피터 지. 스트링거 결정질 에키노칸딘 암모늄염의 형성 및 음이온 교환
CA2362482A1 (en) 1999-03-03 2000-09-08 Eli Lilly And Company Processes for making pharmaceutical oral ecb formulations and compositions
WO2001060796A1 (en) * 2000-02-18 2001-08-23 Meiji Seika Kaisha, Ltd. PHENOXYALKYLAMINE DERIVATIVES USEFUL AS OPIOID δ RECEPTOR AGONISTS
FR2833596B1 (fr) * 2001-12-14 2005-02-18 Aventis Pharma Sa Procede de preparation de derives d'echinocandine
US6991800B2 (en) 2002-06-13 2006-01-31 Vicuron Pharmaceuticals Inc. Antifungal parenteral products
MXPA05011536A (es) * 2003-04-30 2006-01-23 Inst For Pharm Discovery Inc Acidos carboxilicos substituidos con fenilo como inhibidores de la proteina tirosina fosfatasa-1b.
KR101551207B1 (ko) * 2008-09-04 2015-09-08 롬엔드하스전자재료코리아유한회사 신규한 유기 발광 화합물 및 이를 발광재료로서 채용하고 있는 유기 발광 소자
CN102464704B (zh) * 2010-11-05 2013-12-11 上海医药工业研究院 一种化合物及其制备方法和用途
KR102236462B1 (ko) * 2012-03-19 2021-04-08 시다라 세라퓨틱스, 인코포레이티드 에키노칸딘 계열의 화합물에 대한 투여 용법
PL3058958T3 (pl) 2015-02-23 2019-02-28 Selectchemie Ag Kompozycja anidulafunginy
JP6866583B2 (ja) * 2016-07-05 2021-04-28 Dic株式会社 液晶化合物
CN116903706B (zh) * 2023-06-13 2024-05-17 深圳市祥根生物有限公司 一种棘白菌素类药物及其制备方法和用途

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE886575A (fr) * 1979-12-13 1981-06-10 Lilly Co Eli Derives de noyaux peptidiques cycliques, leur preparation et leur utilisation comme agents antifongiques
BE886576A (fr) * 1979-12-13 1981-06-10 Lilly Co Eli Derives de noyaux peptidiques cycliques, leur preparation et leur utilisation comme agents antifongiques
CA2037957A1 (en) * 1990-03-12 1991-09-13 Merck & Co., Inc. N-acylated cyclohexapeptide compounds
GB2241956A (en) 1990-03-16 1991-09-18 Merck & Co Inc N-acylated cyclohexapeptide compounds
US5310726A (en) * 1990-03-19 1994-05-10 Merck & Co., Inc. Lipopeptide compounds
IL97347A0 (en) * 1990-03-19 1992-05-25 Merck & Co Inc Lipopeptide derivatives and antimicrobial compositions containing them
US5330973A (en) * 1990-03-19 1994-07-19 Merck & Co., Inc. Lipopeptide derivatives
CZ288974B6 (cs) * 1992-03-19 2001-10-17 Eli Lilly And Company Acylový derivát echinocandinu, způsob jeho přípravy, farmaceutický prostředek s jeho obsahem a jeho pouľití

Also Published As

Publication number Publication date
DE122008000006I2 (de) 2011-07-21
IL105048A (en) 2001-06-14
HU211562A9 (en) 1995-12-28
IL122315A (en) 2002-03-10
NZ247149A (en) 1996-10-28
DE122008000006I1 (de) 2008-04-17
TW264477B (sv) 1995-12-01
EP0561639A1 (en) 1993-09-22
CZ41693A3 (en) 1994-07-13
ATE217635T1 (de) 2002-06-15
CA2091663C (en) 2007-10-30
JPH0656892A (ja) 1994-03-01
JP3519754B2 (ja) 2004-04-19
CZ288974B6 (cs) 2001-10-17
BR9301232A (pt) 1993-09-21
JP3520071B2 (ja) 2004-04-19
AU6552996A (en) 1996-12-05
YU18593A (sh) 1996-10-09
FI931202A (fi) 1993-09-20
MY136593A (en) 2008-10-31
HUT63637A (en) 1993-09-28
YU49108B (sh) 2004-03-12
IL105048A0 (en) 1993-07-08
KR930019694A (ko) 1993-10-18
NO930948L (no) 1993-09-20
CN1080926A (zh) 1994-01-19
KR100256036B1 (ko) 2000-05-01
NZ299314A (en) 2001-09-28
NL300334I2 (nl) 2008-05-01
ES2174843T3 (es) 2002-11-16
HU225783B1 (en) 2007-09-28
CA2091663A1 (en) 1993-09-20
JP2004115540A (ja) 2004-04-15
LU91406I2 (fr) 2008-03-10
DK0561639T3 (da) 2002-06-17
DE69331922D1 (de) 2002-06-20
JP2002226500A (ja) 2002-08-14
EP0561639B1 (en) 2002-05-15
NL300334I1 (nl) 2008-03-03
NO930948D0 (no) 1993-03-16
PT561639E (pt) 2002-10-31
RU2129562C1 (ru) 1999-04-27
IL122315A0 (en) 1998-04-05
HU9300785D0 (en) 1993-06-28
FI931202A0 (fi) 1993-03-18
NZ512085A (en) 2003-08-29
MX9301457A (es) 1994-02-28
AU3534193A (en) 1993-09-23
CN1036715C (zh) 1997-12-17
AU689391B2 (en) 1998-03-26
DE69331922T2 (de) 2002-08-29

Similar Documents

Publication Publication Date Title
FI118768B (sv) Förfarande för framställning av antifungala cykliska peptider
US5932543A (en) Cyclic peptide antifungal agents and process for preparation thereof
DE69624966T2 (de) Zyklische Hexapeptide mit fungizider Aktivität
MX2007003538A (es) Derivados de ciclosporina 3-eter y 3-tioeter sustituidos para el tratamiento y prevencion de infeccion de hepatitis c.
US6232290B1 (en) Cyclic hexapeptides with antimicrobial activity
JPH11505845A (ja) 環状ペプチド抗真菌剤
US7790744B2 (en) Cyclic peptide antifungal agents and process for preparation thereof
US6384013B1 (en) Cyclic peptide antifungal agents and process for preparation thereof
DE69624167T2 (de) Zyklische Peptide mit fungizider Wirkung
DE69610880T2 (de) Zyklische Peptide mit antifungischer Wirkung
DE69623387T2 (de) Zyklische Peptide mit fungizider Wirkung
US5811400A (en) Peptide derivatives with δ opioid receptor antagonist or mixed μ agδ antagonist effects
DE69626439T2 (de) Zyklische Peptide mit fungizider Wirkung
US6653281B1 (en) Ring modified cyclic peptide analogs
BG65033B1 (bg) Производни на ехинокандин, метод за тяхното получаване и използването им като противогъбично средство
US7166572B1 (en) Cyclohexapeptide compounds, processes for their production and their use as a pharmaceutical
KR20010022295A (ko) 스트렙토그래민, 이의 제조방법 및 이를 함유하는 조성물
CN116903706B (zh) 一种棘白菌素类药物及其制备方法和用途
KR100474161B1 (ko) 에어로트리신 유도체, 이의 제조 방법 및 이를 함유하는 약학조성물
AU1262800A (en) Compounds with growth hormone releasing properties
WO2000020441A2 (en) Cyclic peptides as antifungal agents

Legal Events

Date Code Title Description
SPCF Supplementary protection certificate application filed

Free format text: SPC C20080019

Spc suppl protection certif: C20080019

FG Patent granted

Ref document number: 118768

Country of ref document: FI

Effective date: 20080314

SPCG Supplementary protection certificate granted

Spc suppl protection certif: 321

Extension date: 20180318

MA Patent expired